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he 
 
 
 
1 family of integrins has been primarily studied
as a set of receptors for the extracellular matrix. In
this paper, we deﬁne a novel role for 
 
 
 
3
 
 
 
1 integrin in
association with the tetraspanin CD151 as a component of
a cell–cell adhesion complex in epithelial cells that directly
stimulates cadherin-mediated adhesion. The integrin–
tetraspanin complex affects epithelial cell–cell adhesion at
T
 
the level of gene expression both by regulating expression
of PTP
 
  
 
and by organizing a multimolecular complex
 
containing PKC
 
 
 
II, RACK1, PTP
 
 
 
, 
 
 
 
-catenin, and E-cadherin.
These ﬁndings demonstrate how integrin-based signaling
can regulate complex biological responses at multiple
levels to determine cell morphology and behavior.
 
Introduction
 
Most, if not all, cellular morphogenetic events result from
modulation in cell–cell or cell–substratum adhesion. Tradi-
tionally, integrins are thought to mediate cell–matrix adhesion
and cadherins cell–cell adhesion. There are well-known
exceptions to this rule, such as the leukocyte–endothelium
cell–cell interactions mediated by the 
 
 
 
2 family of integrins
(Carter et al., 1990; Larjava et al., 1990). Nevertheless,
integrins of the 
 
 
 
1 family have primarily been studied as
receptors for the ECM. However, certain members of the
 
 
 
1 family of integrins, when complexed with another family
of transmembrane proteins, known as tetraspanins, have
been hypothesized to be involved in cell–cell adhesion
(Fitter et al., 1999).
Tetraspanins are a group of cell surface molecules that have
four transmembrane domains. Tetraspanins are thought to
play an important role in a variety of normal and pathological
processes, such as cell differentiation, cell motility, egg–sperm
fusion, and tumor cell metastasis (Berditchevski, 2001;
Boucheix and Rubinstein, 2001). In vivo, 
 
 
 
3
 
 
 
1 integrin
and CD151 are coexpressed in a variety of epithelial cells,
including basal keratinocytes of the skin and glomerular
epithelial cells of the kidney (Sterk et al., 2000, 2002). It has
been found that the 
 
 
 
3
 
 
 
1–CD151 complex is very stable
and can withstand conditions that disrupt all other integrin–
tetraspanin and tetraspanin–tetraspanin interactions (Yauch
et al., 1998; Serru et al., 1999). Notably, the interaction of
CD151 and 
 
 
 
3
 
 
 
1 integrin has been found to affect cell
motility and signaling (Zhang et al., 2001; Yang et al.,
2002). Yauch et al. (1998, 2000) reported that the stalk region
of the 
 
 
 
3 extracellular domain (between 570 and 705 aa)
and a region of large extracellular domain of CD151 (between
186 and 217 aa) is important for stable association of these
two molecules (Berditchevski et al., 2001). Tetraspanins are
not found in focal contacts, nor do they appear to have any
effect on ECM adhesion mediated by integrins (Berditchevski
et al., 1996; Berditchevski and Odintsova, 1999). However,
numerous reports have described the localization of tetra-
spanins at sites of cell–cell contact, suggesting a possible role
in cell–cell adhesion tetraspanins in promoting cell–cell
interactions (Fitter et al., 1999; Yanez-Mo et al., 2001).
Several studies have demonstrated that disruption of integrin
function in epithelial cells leads to a loss of the cortical
cytoskeleton and the assembly of actin stress fibers (Carter et
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al., 1990; Hodivala-Dilke et al., 1998; Wang et al., 1999).
In Wang et al. (1999), it was shown that 
 
 
 
3
 
 
 
1 integrin–
deficient collecting duct epithelial cells assembled actin stress
fibers instead of a subcortical cytoskeleton, and that there
was reduced association of the cadherin–catenin complex
with 
 
 
 
-actinin in 
 
 
 
3
 
 
 
1-deficient cells. Here, we show that
association of 
 
 
 
3
 
 
 
1 integrin with CD151 does indeed pro-
mote association of the cadherin–catenin complex with the
actin cytoskeleton and cadherin-mediated cell–cell adhesion.
Two levels of regulation were evident. First, the integrin–
tetraspanin complex regulates the gene expression of PTP
 
 
 
,
a transmembrane protein tyrosine phosphatase previously
shown to be involved in cadherin-mediated adhesion (Brady-
Kalnay et al., 1995, 1998; Hellberg et al., 2002). Second,
we observed a unique complex involving PKC
 
 
 
II, RACK1,
and PTP
 
 
 
 used by integrins to regulate cadherin-mediated
cell–cell adhesion, possibly by modulating tyrosine phos-
phorylation of 
 
 
 
-catenin. It was possible to identify a
large  multimolecular complex containing 
 
 
 
3
 
 
 
1 integrin–
CD151–PKC
 
 
 
II–RACK1–PTP
 
 
 
–E-cadherin–
 
 
 
-catenin,
whose presence in epithelial cells was dependent on the inte-
grin–tetraspanin interaction. The 
 
 
 
3
 
 
 
1 integrin receptors
associated with the cadherin–catenin complex could be dis-
tinguished from those involved in binding laminin. There-
fore, two distinct populations of integrins are present in epi-
thelial cells, one involved in cell–matrix adhesion and
another involved in cell–cell adhesion.
 
Results
 
Expression of chimeric integrin receptors 
on the surface of 
 
 
 
3
 
 
 
1-deficient cells 
and their association with CD151
 
Yauch et al. (2000) previously characterized a set of chimeric
integrin 
 
 
 
 subunits, used here, containing the 
 
 
 
6 extracellu-
lar domain and the 
 
 
 
3 cytoplasmic domain (Fig. 1 A). Un-
der their conditions, and confirmed in our studies (Fig. 1 B),
CD151 was only able to interact with 
 
 
 
 subunits containing
the 
 
 
 
3-stalk region. 
 
 
 
3
 
 
 
1-Deficient cells were stably trans-
fected with 
 
 
 
6/
 
 
 
3 chimeric integrins, and heterodimeric ex-
pression of chimeric 
 
 
 
 subunits with 
 
 
 
1 integrin was con-
firmed (Fig. 1 B); henceforth, transfected cell lines are
designated as 
 
 
 
3-stalk and 
 
 
 
6-stalk. As in previously pub-
lished studies (Yauch et al., 2000), only wild-type 
 
 
 
3 or
 
 
 
3-stalk subunits interacted with CD151 (Fig. 1 C), the
amount of CD151 being equal in all cell lines (Fig. 1 C).
To further confirm the specificity of the 
 
 
 
3
 
 
 
1–CD151 in-
teraction, it was demonstrated that CD151 could not be
Figure 1. Association of integrins and CD151. In all panels, the cell lines are designated below the panel showing the first blot; when shown, 
reblots are below the cell line designations. In all figures: WT, wild-type cells; KO,  3 1 integrin-deficient cells;  3-stalk, cells expressing 
 6/ 3 chimeric integrin that has  3-stalk region;  6-stalk, cells expressing  6/ 3 chimeric integrin that has  6-stalk region. (A) A schematic 
representation of the chimeric   integrin subunits, showing the inclusion of either the  3- or  6-stalk region. (B) Immunoprecipitation of 
surface-labeled cells using a polyclonal antibody to the  3 integrin cytoplasmic domain or an  6 mAb. Cells were labeled with biotin, lysed 
using 1% Brij 96 buffer, and lysates were subjected to immunoprecipitation either with the  3 cytoplasmic domain antibody or with the  6 
mAb. (C) Coimmunoprecipitation of integrins and CD151. Cell lines were extracted in 1% Triton X-100 buffer and immunoprecipitated with 
either the  3 or  6 antibody or with the CD151 antibody and immunoblotted with CD151 antibody. The immunoprecipitation and immunoblot 
antibodies are designated above or below the panels. (D) CD151 shRNA. Wild-type cells were infected with lentivirus containing CD151 
shRNA. Cells were extracted in 1% Triton X-100 buffer and tested for CD151 expression and for their association with  3 1 integrin. One of 
the CD151 shRNAs (CD151 shRNA) blocked the expression and the other one did not (control shRNA) and was used in subsequent experiments 
as a negative control. (E) Adhesion assay. Plates were coated with laminin-1 or human placental laminin (contains mainly laminin-10 and -11), 
and adhesion of the cells was analyzed by an MTT assay. Each bar represents the mean of five wells, and SEM bars are shown. 100% adhesion 
is defined as the adhesion of  6-stalk cells for laminin-1 and wild-type cells for laminin-10 and -11. 
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coimmunoprecipitated with 
 
 
 
6
 
 
 
1 or 
 
 
 
6
 
 
 
4 integrins (Fig. 1,
B and C). Under other experimental conditions, generally in-
volving the use of mild detergents in the cell extraction, the
 
 
 
6 subunit has been found to interact with CD151 (Zhang et
al., 2002). This could also be demonstrated in the cell lines
used in this paper (unpublished data), but under the more
stringent conditions of Triton X-100 extractions, there was no
demonstrable interaction of CD151 with the 
 
 
 
6-stalk region.
Multiple tetraspanins interact with 
 
 
 
3
 
 
 
1 integrin. Len-
tiviral-based small hairpin RNA (shRNA; Rubinson et al.,
2003) vectors were constructed to allow specific inhibition
of CD151 expression (Fig. 1 D). Two of three constructs
sufficiently inhibited CD151 expression (Fig. 1 D), no
CD151 was found in association with 
 
 
 
3
 
 
 
1 integrin. The
shRNA vector that did not inhibit CD151 was used in fur-
ther experiments as a negative control.
 
 
 
6/
 
 
 
3 chimeric integrins mediate adhesion 
to laminin-1, -10, and -11
 
Although 
 
 
 
3
 
 
 
1 and 
 
 
 
6
 
 
 
1 are both receptors for laminin,
 
 
 
3 1 preferentially binds laminins 5, 10, and 11, whereas
 6 1 has been shown to have a less restricted laminin-binding
repertoire (Delwel et al., 1994; Kikkawa et al., 1998; Yauch et
al., 2000). Cells expressing the  6 extracellular domain ( 3-
stalk and  6-stalk) showed increased adhesion to laminin-1 in
comparison with wild-type and mutant cells (Fig. 1 E). Con-
sistent with the ability of both  3 1 and  6 1 to bind lami-
nin-10 and -11, wild-type and chimeric integrin-expressing
cell lines showed increased adhesion to laminin-10 and -11 in
comparison with  3 1 integrin–deficient cells. Importantly,
the heterodimer of  1 and the  6-stalk–containing subunit
mediated adhesion to laminin-10 and -11 despite its inability
to interact with CD151. This finding is consistent with obser-
vations that integrin–tetraspanin interactions are not involved
in modulating the cell–ECM adhesive functions.
 3 1–CD151 complex stimulates E-cadherin–mediated 
cell–cell adhesion
Cells were trypsinized in the presence of calcium to preserve
cadherins (Takeichi, 1977) and kept in suspension, such
that the ability of cells to aggregate could be studied inde-
pendently of cell migration. 50% of the input wild-type cells
and  3-stalk–expressing cells became aggregated within 1 h
in suspension, and after 3 h, nearly 80% of the cells were
found in clusters. In contrast, only 20% of mutant and  6-
stalk–expressing cells were found in clusters at 1 h, and only
30% after 3 h in suspension (Fig. 2 A). Similarly, expression
of CD151 shRNA decreased the aggregation of wild-type
cells down to levels observed for mutant or  6-stalk–
expressing cells (Fig. 2 A). Thus, cell aggregation appears to
be stimulated by the integrin–tetraspanin interaction.
The hypothesis that integrin–tetraspanin interactions stim-
ulated cadherin-mediated adhesion was examined using an
HAV peptide (Makagiansar et al., 2001) or an E-cadherin–
blocking antibody (DECMA). Both the HAV peptide and
the E-cadherin–blocking antibody were able to eliminate
the greater aggregation observed with wild-type or  3-stalk–
expressing cells in comparison with mutant and  6-stalk–
expressing cells (Fig. 2 A). A control peptide with the HAV
sequence reversed to VAH had no effect on cell–cell aggrega-
tion. An mAb (Ralph 3.2) known to block binding of  3 1-
expressing cells to laminin had no effect on cell aggregation
(unpublished data), serving as a negative control for the
E-cadherin–blocking antibody. This result also suggested
that the laminin binding site of  3 1 integrin was not directly
involved in cell aggregation. The role of E-cadherin was con-
Figure 2. Cadherin-mediated cell–cell adhesion. (A) Cell aggregation 
assay. Cells were kept in suspension for the designated time periods 
in complete medium, in medium with the addition of the HAV 
hexapeptide, or in the presence of E-cadherin–blocking antibody. 
The number of single cells and the number of cells in clusters were 
counted. The standard curve was used to determine the optimum 
concentration of HAV hexapeptide. (B) Binding assay. 96-well plates 
were coated with E-cadherin/Fc recombinant protein and binding of 
control, E-cadherin–blocking antibody–treated and HAV peptide–
treated cells were measured by the MTT assay. Binding of wild-type 
cells to E-cadherin was considered as 100%, representing binding 
of over 95% of the input cells. Each bar is the mean of five wells 
and SEMs are shown.1354 The Journal of Cell Biology | Volume 163, Number 6, 2003
firmed using an adhesion assay in which cells were allowed to
adhere to E-cadherin/Fc protein–coated dishes (Fig. 2 B).
This assay demonstrated greater binding of wild-type or  3-
stalk–expressing cells, and adhesion could be blocked using
either the HAV peptide or the E-cadherin–blocking anti-
body. Cells did not bind significantly to N-cadherin/Fc
(Utton et al., 2001)–coated dishes (Fig. 2 B). Thus, the
increased aggregation observed in wild-type and  3-stalk–
expressing cells appears to be dependent on E-cadherin.
The integrin–tetraspanin interaction is required for the 
interaction of the cadherin–catenin complex with the 
subcortical cytoskeleton
Cadherin-mediated cell–cell interactions progress from weak
to strong interactions through the assembly of cadherin–
catenin complexes and the association of these complexes
with the subcortical actin cytoskeleton (Braga, 2000). E-cad-
herin and  -catenin were present at cell–cell contacts in all
cell lines, although cell–cell contacts appeared more diffuse
in mutant and  6-stalk cells (Fig. 3 A).  -Actinin is an ac-
tin-binding protein shown to be involved in associating the
cadherin–catenin complex with the cytoskeleton (Knudsen
et al., 1995; Nieset et al., 1997).  -Actinin was present at
the cell–cell junction of wild-type and  3-stalk–containing
cells but stained diffusely in cells where integrin–tetraspanin
interaction was absent, suggesting that the cadherin–catenin
complex does not colocalize with  -actinin in these cells.
Moreover, a subcortical actin cytoskeleton was present in
both wild-type and  3-stalk cells, whereas actin stress fibers
were more prominent in mutant and  6-stalk cells (Fig. 3
A) or in cells expressing shRNA for CD151 (Fig. 3 A).
To quantitatively assess the dependency of cadherin–cate-
nin interactions on association of  3 1 with CD151,
E-cadherin was immunoprecipitated from the cell lines, and
the immunoprecipitate was immunoblotted for  - and
 -catenin components of cadherin–catenin complexes (Fig.
3 B). The abundance of E-cadherin and the amount of
 - and  -catenin complexed with E-cadherin did not appear
to be dependent on the integrin–tetraspanin interaction. In
contrast, there was a marked difference between  3- and  6-
stalk cells in the amount of actin and  -actinin that could be
coimmunoprecipitated with the cadherin–catenin complex
(Fig. 3 B). Inhibition of CD151 expression with shRNA
also inhibited the association of  -actinin with the cad-
herin–catenin complex (Fig. 3 C). Thus, in the cell lines un-
der study, the  3 1 integrin–CD151 association appears to
regulate the interaction of the assembled cadherin–catenin
complex with components of the cytoskeleton.
 -Catenin tyrosine phosphorylation is regulated by the 
integrin–tetraspanin interaction
The association of E-cadherin with  -catenin can be regu-
lated by the tyrosine phosphorylation of  -catenin (Muller
et al., 1999; Roura et al., 1999), and tyrosine phosphoryla-
tion of  -catenin generally has been correlated with a loss of
epithelial morphology (Ozawa and Kemler, 1998; Provost
and Rimm, 1999). Consistent with these observations, loss
of the  3 1–CD151 interaction leads to increased tyrosine
Figure 3. Cadherin–catenin complexes. (A) Immunocytochemistry. Cells 
were stained with different antibodies indicated at the top of each panel 
and cell lines are designated at the left side of each panel. Phalloidin-Texas 
red was used to stain for actin. (B) E-cadherin immunoprecipitation. Cells 
were extracted in 1% Triton X-100 buffer and equal amounts of cell extract 
from each cell lines were immunoprecipitated and blotted. Cell lines and antibodies for immunoprecipitation and immunoblot are shown at 
the bottom and top of each panel, respectively. (C) Inhibition of CD151 expression with shRNA dissociated  -actinin from the cadherin–catenin 
complex. (D) Tyrosine phosphorylation of  -catenin. Cells were treated with 1 mM sodium orthovanadate before extraction. All buffers used 
in this experiment were supplemented with 1 mM sodium orthovanadate. The top panel is the phosphotyrosine blot, and the bottom panel is 
the reblot with the same antibody used for immunoprecipitation. (E) A model summarizing the results of this figure.Integrin regulation of cell–cell adhesion | Chattopadhyay et al. 1355
phosphorylation of  -catenin (Fig. 3 D). It was also ob-
served that the total amount of  -catenin present in wild-
type and  3-stalk cells is higher than that of mutant and  6-
stalk cells (Fig. 3 D), even though the amount of  -catenin
associated with E-cadherin does not differ (Fig. 3 B). How-
ever, our work does not support the hypothesis that tyrosine
phosphorylation of  -catenin dissociates it from E-cadherin,
at least in the cells under study. This is because when cells
are pretreated with orthovanadate to preserve phosphoryla-
tion (as in Fig. 3 D but not Fig. 3 B), the reblot with an
anti– -catenin antibody shows all the  -catenin in  3 1-
deficient and  6-stalk chimera–expressing cells as a higher
molecular mass band than that observed in wild-type and
 3-stalk chimera–expressing cells (Fig. 3 D), presumably re-
flecting a hyperphosphorylated state. Combined with our
additional observation that the E-cadherin– -catenin associ-
ation did not differ depending on the integrin–tetraspanin
interaction, our results suggest that tyrosine-phosphorylated
 -catenin remains associated with E-cadherin in these cell
lines. The results are summarized in a model (Fig. 3 E).
PTP  expression is regulated by 
integrin–tetraspanin association 
The increased tyrosine phosphorylation observed in mutant
cells led us to examine the possibility that a phosphatase ac-
tivity was decreased in the absence of the integrin–tetraspa-
nin interaction. Several tyrosine phosphatases have been
shown to be associated with E-cadherin (Lilien et al., 2002).
PTP  is a transmembrane protein tyrosine phosphatase that
can interact with several classical cadherins, including E-cad-
herin, and can regulate E-cadherin–mediated cell–cell adhe-
sion (Brady-Kalnay et al., 1995, 1998; Hellberg et al.,
2002). The proteolytic form of PTP  (detected at 100 kD)
was found to be associated with cadherin–catenin complex
only in wild-type and  3-stalk–expressing cells, suggesting a
potential role for PTP  in regulating the tyrosine phosphor-
ylation of the cadherin–catenin complex. Indeed, upon fur-
ther analysis, it was determined that the full-length (200
kD) and proteolytic (100 kD) forms of PTP  are expressed
only in the cells where the integrin–tetraspanin interaction is
present, neither form of PTP  or PTP  RNA was found in
mutant or  6-stalk–expressing cells (Fig. 4, A and B). This
finding indicates a role for the  3 1–CD151 complex in
modulating PTP  gene expression, an area of future studies.
The integrin–tetraspanin complex is required 
for PTP  regulation of cell–cell adhesion
Because PTP  is surprisingly absent in mutant and  6-stalk–
expressing cells, it became important to evaluate whether
PTP  can regulate cell–cell adhesion in epithelial cells such as
those in our work. To first examine whether phosphatases
could play a role in integrin–tetraspanin-stimulated cell–cell
adhesion, cells were treated with a tyrosine phosphatase inhib-
itor (bpV/Phen) and cell–cell aggregation, or adhesion of the
cells to recombinant E-cadherin protein was studied. Treat-
ment with a tyrosine phosphatase inhibitor blocked the cell
aggregation (Fig. 5 A) or E-cadherin/Fc binding of wild-type
cells or  3-stalk–expressing cells down to levels observed for
mutant or  6-stalk–expressing cells (Fig. 5 B).
A direct role for PTP  in  3 1–CD151-stimulated cell–
cell adhesion was demonstrated by infecting cells with baculov-
iruses encoding either wild-type or catalytically inactive PTP 
(C-S mutant) each fused to GFP. Equivalent levels of baculo-
viral-encoded PTP  were expressed in each of the cell lines (Fig.
5 C), and direct Western blots after baculoviral infection dem-
onstrated equivalent expression of exogenous PTP  in all cell
lines, that was only in two- to threefold excess of the level of
endogenous PTP  in wild-type cells (Fig. 5 D). Endogenous
PTP  could not be detected in infected cells (Fig. 5 D), sug-
gesting that there is tight regulation of the maximal amount of
PTP  that can be expressed in these cells. Expression of the C-S
mutant decreased cell aggregation and adhesion to E-cad-
herin/Fc of wild-type and  3-stalk cells, dissociated  -actinin
from the cadherin–catenin complex, and resulted in disorgani-
zation of subcortical actin (Fig. 5, A, B, D, and E). Therefore,
these results predict that expression of the wild-type form of
PTP  in mutant or  6-stalk–expressing cells would restore a
wild-type phenotype to mutant or  6-stalk–expressing cells.
However, expression of wild-type PTP  did not rescue cell ag-
gregation, adhesion to E-cadherin/Fc, or association of the cad-
herin–catenin complex with the cytoskeleton in mutant and
 6-stalk–expressing cells (Fig. 5, A, B, D, and E), indicating
the absolute requirement for the  3 1–CD151 complex to
stimulate E-cadherin–mediated cell–cell adhesion. Moreover,
expression of the PTP  C-S mutant in wild-type cells also re-
sulted in tyrosine phosphorylation of  -catenin, but wild-type
PTP  could not decrease tyrosine phosphorylation in  6-stalk
or mutant cells. Expression of an enzymatically active baculovi-
ral PTP  in mutant cells was confirmed by Western blot (Fig.
Figure 4. Association of the cadherin–catenin complex 
with PTP . Antibodies used for immunoprecipitation 
and immunoblotting are described at the top of each 
panel and cell lines are designated at the bottom. (A) 
PTP  coimmunoprecipitation. PTP  is expressed only 
in cells where  3 1–CD151 complex was present and 
coimmunoprecipitated with E-cadherin and  -catenin. 
(B) RT-PCR. Total RNA was extracted from the cells 
and RT-PCR using primers for PTP . No-RT, negative 
control using wild-type RNA but no reverse transcriptase. 
 -Actin RT-PCR was used as a control. (C) A model 
summarizing the results of this figure.1356 The Journal of Cell Biology | Volume 163, Number 6, 2003
Figure 5. PTP  baculovirus infection. (A) Cell aggre-
gation assays. Cells were treated with either 1 mM 
phosphatase inhibitor (bpV [Phen]) or infected with 
baculovirus expressing either wild type or the C-S 
mutant of PTP , each as a GFP fusion protein. (B)
E-cadherin/Fc adhesion assay after baculovirus infection. 
Each bar is the mean of five wells and SEMs are shown. 
(C) FACS
® analysis after baculovirus expression. The 
shaded curve shows uninfected cells, and the unshaded 
curve shows infected cells. (D) Immunoprecipitation. 
Cells were extracted in 1% Triton X-100 buffer after 
baculovirus infection. Cadherin–catenin immunopre-
cipitations and the  -catenin tyrosine phosphorylation 
assay were performed as described in Materials and 
methods. (E) Phalloidin staining of baculovirus-infected 
cells. (F) A model summarizing the results of this figure. 
When wild-type PTP  is present in  6-stalk cells, it is 
not associated with the cadherin–catenin complex 
(middle model); hence, cadherin-mediated cell–cell adhesion is weak. When the C-S form of PTP  is overexpressed in wild-type cells (right 
model), it displaces wild-type PTP  from its association with the cadherin–catenin complex;  -catenin becomes phosphorylated; and there is 
weak cadherin-mediated adhesion.Integrin regulation of cell–cell adhesion | Chattopadhyay et al. 1357
Figure 6. Interactions of the integrin–tetraspanin complex. (A) Coimmunoprecipitations of the integrin–tetraspanin complex. Cell lines and 
antibodies for immunoprecipitation and immunoblot are shown at the top and bottom of each panel, and cell lines are designated as in Fig. 1. 
In A–C, cells were cross-linked with 1 mM DSP at 4 C for 1 h before extraction. Cells were extracted in 1% Triton X-100 buffer and subjected 
to immunoprecipitation either with  3 or  6 antibody. The control  3 reblot of the  3 immunoprecipitation is shown in Fig. 1 C, as this required 
nonreducing conditions and was run in a separate gel. An  6 immunoprecipitation was used as a negative control. CD151 RNAi experiment. 
CD151shRNA or control shRNA was expressed in wild-type cells before immunoprecipitation of  3 1 integrin and immunoblotting for RACK1. 
(B) Sequential immunoprecipitations showing the same pool of PTP  is associated with  3 1–CD151 complex and the cadherin–catenin 
complex. Cells were cross-linked before extraction. Proteins were extracted from  3 immunoprecipitates with 1% Triton X-100 buffer containing 
0.5% SDS. The second immunoprecipitation was done with PTP  antibody and the immunoblot was developed either with E-cadherin or 
 -catenin antibodies. The negative control in the rightmost lane of each panel is a wild-type extract in which the primary antibody is omitted 
from the second immunoprecipitation. The reblots with PTP  serve as positive controls for the immunoprecipitations. After obtaining the first 
blots, the membrane was stripped in buffer containing 62.5 mM Tris-HCl, pH 6.7, 0.7%  -mercaptoethanol, and 2% SDS for 30 min at 50 C 
and reprobed with a PTP  antibody. (C and D) Inhibition of PKC–RACK1 interaction. Cells were treated with 1  M of carrier or PKC II trans-
location inhibitor peptide, as designated above the panels, 1 h before beginning the aggregation assay or before extraction. (C) Translocation 
inhibitor effects on the  3 1 integrin–E-cadherin–PTP  association. (D) Effect of translocation inhibitor on cell aggregation and cadherin 
complex association. The inhibitor decreased aggregation of wild-type and  3-stalk cells. Each bar of the aggregation assay histogram is the 
mean of five wells, and SEMs are shown. Association with  -actinin is lost, but the E-cadherin– -catenin association is not affected.1358 The Journal of Cell Biology | Volume 163, Number 6, 2003
5 D) and by immunoprecipitation of PTP  followed by in
vitro phosphatase assays (Fig. S1, available at http://www.
jcb.org/cgi/content/full/jcb.200306067/DC1). A model sum-
marizing these interactions is provided in Fig. 5 F.
The  3 1–tetraspanin complex stabilizes the interaction 
of PTP  with the cadherin–catenin complex 
The failure of wild-type PTP  to rescue mutant or  6-stalk
cells suggested that the presence of the integrin–tetraspanin
complex on the cell membrane could also affect the associa-
tion of PTP  with the cadherin–catenin complex. Previous
studies demonstrated an interaction of the  3 1–CD151
complex with PKC II (Zhang et al., 2001) and an interaction
between PTP  and the adaptor protein RACK1 (Mourton et
al., 2001). Because activated PKC II binds RACK1 (Ron et
al., 1994; Mochly-Rosen, 1995; Csukai et al., 1997), these re-
sults led us to investigate the possibility that the integrin–tet-
raspanin complex could stabilize the interaction of PTP 
with the cadherin–catenin complex through the establishment
of a complex that contains PKC II, RACK1, and PTP . Af-
ter cross-linking, PKC II, RACK1, and PTP  could be
coimmunoprecipitated with  3 1 or the  3-stalk–containing
integrin heterodimer, but they were not present in immuno-
precipitates from the  6-stalk–expressing cells (Fig. 6 A). Ex-
pression of CD151 shRNA also abrogated the association of
RACK1 with the integrin–tetraspanin complex (Fig. 6 A). Se-
quential immunoprecipitations of cross-linked cells were used
to demonstrate that the same pool of PTP  associated with
 3 1–CD151 and with the cadherin–catenin complex (Fig.
6 B). As negative controls, none of these components could be
coimmunoprecipitated from wild-type cells with  6 1 inte-
grin. As additional negative controls, neither CD44, an abun-
dant membrane protein, nor Ezrin, an abundant peripheral
membrane protein associated with the cytoskeleton, could be
coimmunoprecipitated with  3 1 integrin, PTP , E-cad-
herin (Fig. 6 A), or RACK1 and PKC II (not depicted). Ad-
ditionally, the epidermal growth factor receptor, although
present in all cells, was not coimmunoprecipitated with
 3 1–CD151 (unpublished data).
The PKC II–RACK1 interaction, known to be depen-
dent on activation of PKC II (Ron et al., 1994), is only
observed in wild-type or  3-stalk cells, indicating that asso-
ciation of PKC II with  3 1 integrin–CD151 may acti-
vate PKC II. To further establish the importance of the
PKC II–RACK1 interaction in cell aggregation, cells were
treated with a PKC II translocation inhibitor peptide that
blocks the association of PKC II with RACK1 (Stebbins
and Mochly-Rosen, 2001; Fig. 6 C). This showed that the
association of PTP  with E-cadherin or  3 1 integrin was
dependent on the association of PKC II with RACK1 (Fig.
6 C). Moreover, blocking the interaction of PKC II and
RACK1 decreased cell aggregation of integrin–tetraspanin-
expressing cells and dissociated  -actinin from the cad-
herin–catenin complex (Fig. 6 D). In contrast, association of
PTP  with RACK1 was constitutive and not affected by the
PKC II translocation inhibitor peptide (unpublished data).
The translocation inhibitor peptide also did not affect the
interaction of E-cadherin and  -catenin (Fig. 6 D). To-
gether, these results indicate that the association of  3 1
with CD151 is required to stabilize an interaction between
PKC II and RACK1–PTP  that regulates the interaction
of the cadherin–catenin complex with the cytoskeleton.
 3 1 integrins are expressed on the lateral surface 
of the epithelial cells and can act as members 
of the cell–cell adhesion complex
Some integrins, including  3 1 integrin, are often found in a
basolateral distribution, particularly in developing epithelia.
Confocal microscopy demonstrated the lateral localization of
 3 1 in  3-stalk and  6-stalk–expressing cells (Fig. 7 A). To-
gether with the preceding data, this suggests a model in which
 3 1 in basal membranes mediates cell–matrix adhesion,
whereas  3 1–CD151 in lateral membranes modulates cell–
cell adhesion. To further examine the hypothesis that  3 1
molecules associated with cadherin–catenin complexes were
separate from those binding laminin, and the converse sit-
uation, sequential immunoprecipitations were performed.
DiPersio et al. (1995) had shown that it is possible to cross-
link  3 1 integrin to the underlying ECM before immuno-
fluorescent staining. Using a similar approach, cells plated on
a laminin-5–rich matrix were cross-linked and extracted, and
the immunoprecipitate obtained with an anti– 3 integrin an-
tibody was reimmunoprecipitated with anti–laminin-5, and
then blotted for E-cadherin, which was not detected (Fig. 7
B). Laminin-5 could be detected after reblot, serving as a pos-
itive control for the immunoprecipitations. In the converse
experiment, cells were sequentially immunoprecipitated with
anti– 3 integrin and anti–E-cadherin, and then blotted for
laminin-5, which was not detected, with the reblotting for
E-cadherin serving as a positive control (Fig. 7 B). Both exper-
iments showed that distinct pools of  3 1 integrin receptors
were either binding laminin-5 or associated with E-cadherin,
but not both. To further determine whether the ECM ligand-
binding properties of  3 1 integrin affected its association
with E-cadherin and PTP , cells were plated on fibronectin
instead of laminin-5 or -10 and -11. Plating on fibronectin
had no effect on the association of  3 1 with CD151,
Figure 7. Expression of  3 1 integrin on the lateral surface of 
epithelial cells. (A) Immunofluorescence staining of  3 1. The xz 
axis is shown. Staining for  3 1 integrin showed lateral expression 
along the entire z-axis. Cell lines are shown above each panel. (B) 
Sequential immunoprecipitations. Cells were treated with 1 mM DSP 
before extraction. Cell lines and antibodies for immunoprecipitations 
and immunoblots are shown above each panel. Lane C is the negative 
control in which the primary antibody is omitted from the second 
immunoprecipitation.Integrin regulation of cell–cell adhesion | Chattopadhyay et al. 1359
PKC II, RACK1, or PTP , nor did it affect the expression
or activity of total PTP  or that associated with  3 1 inte-
grin (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200306067/DC1), supporting the conclusion that cell–
cell interaction is regulated by  3 1 situated at the cell–cell
junction and not dependent on interaction of  3 1 with
components of the ECM.
Discussion
This paper elucidates the mechanism through which the
 3 1 integrin–CD151 complex stimulates cadherin-medi-
ated cell–cell adhesion. In contrast to previously identified
roles for  3 1 integrin as a receptor for the ECM, we demon-
strate that a distinct pool of  3 1 is located along lateral
membranes, and is associated with the cadherin–catenin com-
plex. Previous studies have not identified the mechanism
whereby cell–cell adhesion is affected by an interaction of inte-
grin and tetraspanin proteins. In this work, we provide direct
evidence that cell–cell adhesion regulated by the  3 1–
CD151 complex is mediated by the cadherin family of cell ad-
hesion molecules. One major pathway through which the
integrin–tetraspanin complex affects cadherin-mediated adhe-
sion is the regulation of expression of PTP . PTP  expression
and activity is crucial for stable interaction of the cadherin–
catenin complex with the cytoskeleton and for maintaining
 -catenin in a hypophosphorylated state. It is not yet proven
whether phosphorylation of  -catenin is directly responsible
for regulating the interaction of the cadherin–catenin complex
with  -actinin or other components of the cytoskeleton. The
 3 1–CD151 complex also organizes the multimolecular
association of PKC II, RACK1, PTP , E-cadherin, and
 -catenin. Because it has previously been demonstrated that
purified PTP  binds E-cadherin in vitro in the absence of inte-
grin–tetraspanin complexes (Brady-Kalnay et al., 1995, 1998),
it is likely that this multimolecular association involving inte-
grin–tetraspanin complexes PKC II and RACK1 stabilizes the
interaction of PTP  with the cadherin–catenin complex. A
model that summarizes these results is shown in Fig. 8.
Integrin function is becoming increasingly complex, a tradi-
tional view of integrins as receptors for the ECM represents
only a subset of integrin function. Recent studies on  3 1 in-
tegrin in keratinocytes suggested a role as a transdominant in-
hibitor of other integrins (Hodivala-Dilke et al., 1998). In this
case, increased adhesion to fibronectin and type IV collagen,
which is assumed to be mediated by other integrins, was ob-
served in cells deficient for  3 1. Might the decreased cell–
cell adhesion observed in the absence of the integrin–tetraspa-
nin interaction be due to similar loss of inhibitory influences
on other integrins? Certainly, promigratory signals from inte-
grins may have the consequence of increasing tyrosine kinase
activity and inhibiting cadherin-mediated adhesion. Regula-
tory cross-talk between these pathways and the regulation of
cadherin-mediated adhesion by the integrin–tetraspanin com-
plex is a fertile ground for future investigations.
There has been relatively little study of how expression of
specific integrin repertoires may generate specific patterns of
gene expression. Previously, the expression of MMP9 was
shown to be activated in immortalized keratinocytes in the
absence of  3 1 integrin (DiPersio et al., 2000), providing
at least one example of a gene expression difference related
to  3 1 expression. The dependence of PTP  expression
on the  3 1–tetraspanin interaction demonstrates how epi-
thelial morphology and adhesive behavior can be dramati-
cally affected by differences in gene expression. Activation of
phosphatase and kinase expression based on interactions of
integrins with ECM ligands or other cell surface molecules,
as shown here, provides an indication of how the integrin
repertoire may affect cell migration or cell–cell interaction
during development or tumorigenesis.
Regulation of cadherin–catenin association
Cadherin-mediated adhesion is regulated through the as-
sembly of cadherin–catenin complexes at the cadherin cyto-
plasmic domain. The assembly of these complexes is essen-
tial for the transition from weak to strong cell–cell contacts.
There are different observations with regard to the specific
molecular interactions that are affected by signaling events
regulating cell–cell interaction and cell morphology. For ex-
ample, several studies that either increased kinase activity
through stimulation with EGF or decreased phosphatase ac-
tivity using pervanadate or phosphatase mutants demon-
strated decreased interaction between a cadherin–catenin
complex and the cytoskeleton (Balsamo et al., 1998; Hazan
and Norton, 1998; Ozawa and Kemler, 1998). This de-
creased interaction was correlated with increased tyrosine
phosphorylation of  -catenin. Other studies have shown
that tyrosine phosphorylation of  -catenin results in de-
creased interaction of  -catenin with E-cadherin (Muller et
al., 1999; Roura et al., 1999). In Wang et al. (1999), we ob-
served yet another level of regulation between the cadherin–
catenin complex and  -actinin shown here to be dependent
on the integrin–tetraspanin interaction. Wang et al. also de-
tected no integrin-dependent difference in the  -catenin–
 -catenin association, confirmed in this work. It is possible
that these different observations reflect the distinct cell types
used in the respective studies and the different kinase and
phosphatase activities present therein. As discussed previ-
ously, our paper does not support the hypothesis that tyro-
sine phosphorylation of  -catenin dissociates it from E-cad-
herin. However, it is important to note that there are several
tyrosine residues in  -catenin, and it is not known if the ty-
Figure 8. A model for  3 1 as a component of the cell–cell adhesion 
complex. The integrin–tetraspanin complex present on the lateral 
surface of the cells induced expression of PTP  and can organize a 
multimolecular complex containing  3 1–CD151–PKC II–RACK1–
PTP – -catenin–E-cadherin.1360 The Journal of Cell Biology | Volume 163, Number 6, 2003
rosine residues phosphorylated in our cell lines are the same
identified in a previous paper (Roura et al., 1999).
The HAV sequence is conserved among several members of
the cadherin family, and HAV-containing peptides have his-
torically been used to block homophilic interaction between
cadherin molecules. Renaud-Young and Gallin recently pub-
lished a paper in which mutation of the HAV sequence did
not affect homophilic adhesion, leading them to suggest that
the HAV sequence may not be involved in the initial cadherin
homophilic interaction (Renaud-Young and Gallin, 2002).
This possibility is consistent with our results because the HAV
peptide and the phosphatase inhibitor blocked adhesion of
wild-type cells to E-cadherin/Fc down to levels observed for
knockout cells, whereas the E-cadherin–blocking antibody
entirely blocked adhesion to E-cadherin/Fc.
Integrins, tetraspanins, and cell transformation
Our results lead us to hypothesize that neoplastic transfor-
mation of a cell is due to both the activation of specific
oncogenes and the loss of signaling molecules from inte-
grin–tetraspanin complexes. In a normal epithelial cell, in-
tegrin–tetraspanin complexes direct expression of PTP ,
which binds RACK1 and establishes an integrin–tetra-
spanin-dependent link to the cadherin–catenin complex,
thereby stimulating cadherin-mediated cell–cell adhesion.
The RACK1 scaffolding protein binds to the Src tyrosine ki-
nase, and binding of RACK1 to PTP  or Src is mutually ex-
clusive (Mourton et al., 2001). In a neoplastic cell, increased
levels of activated Src may displace PTP  from RACK1 and
suppress cadherin-mediate adhesion, or loss of  3 1 inte-
grin expression may result in a complete loss of PTP  ex-
pression, exacerbating the affect of activated oncogenes.
Hellberg et al. (2002) recently studied the role of PTP  in
conferring cadherin-dependent cell–cell adhesion in prostate
carcinoma cells. Both Hellberg et al. (2002) and the present
work demonstrate the importance of PTP  in regulating
E-cadherin–mediated adhesion. In contrast to the observations
of Hellberg et al., we demonstrated that the phosphatase ac-
tivity of PTP  is required to increase E-cadherin–dependent
adhesion. Because that work used prostate carcinoma cells,
this difference may reflect different levels of activated tyrosine
kinases or different integrin–tetraspanin complexes within the
respective cell types that rendered the cells more or less sensi-
tive to the phosphatase activity of PTP . In support of this
hypothesis, N-cadherin–dependent neurite outgrowth does
require PTP  tyrosine phosphatase activity (Burden-Gulley
and Brady-Kalnay, 1999). As demonstrated in Hellberg et al.,
PTP  expression is variable among carcinoma cells lines. It
will be of interest to examine various transformed cell lines
and determine if expression of PTP  correlates with the pres-
ence of integrin–tetraspanin complexes. Not all epithelial cells
in mammals express  3 1 integrin, and it is likely that other
closely related integrins that are also known to associate with
tetraspanins may function similarly in other cell types.
In summary, this paper identifies a new role for  3 1 and
perhaps other integrins as components of cell–cell adhesion
complexes. Association with tetraspanins appears essential
for this function, and integrin–tetraspanin complexes may
direct specific patterns of gene expression in addition to di-
recting protein–protein interactions at the membrane. In the
future, consideration of the role of integrins in disease pro-
cesses that involved changes in cell morphology, such as epi-
thelial to mesenchymal transitions in fibrosis, or tumor pro-
gression, will need to consider this new role for integrins.
Materials and methods
Antibodies, peptides, and other materials
Rabbit polyclonal anti- 3 1 antibody was obtained from R. Hynes (Massa-
chusetts Institute of Technology, Cambridge, MA; DiPersio et al., 1995); rab-
bit polyclonal anti-GFP was obtained from P. Silver (Dana-Farber Cancer
Center, Boston, MA); monoclonal anti-CD151 11b1-G4 (Sincock et al.,
1997). mAbs against intracellular domain of PTP  (SK15 and SK18; Brady-
Kalnay et al., 1993). Anti–integrin  6 A6ELE was obtained from M. Hemler
(Dana-Farber Cancer Center; Lee et al., 1995). E-cadherin antibody ECCD-2
for immunofluorescence was purchased from Zymed Laboratories; E-cad-
herin–blocking antibody (monoclonal antiuvomorulin, clone DECMA-1) and
anti– -actinin clone BM-75.2 antibody was purchased from Sigma-Aldrich;
E-cadherin (clone 36),  -catenin (clone 14),  -catenin (clone 5), and RACK1
(clone 20) antibodies were purchased from BD Biosciences; antiphosphoty-
rosine antibody 4G10 was purchased from Upstate Biotechnology; and anti-
PTP  (C-20), anti- 6 (N-19), anti-PKC II (C-18), and anti- 3 1 (Ralph 3.2)
were purchased from Santa Cruz Biotechnology, Inc. Anti- 6 (MA6) for im-
munoprecipitation and monoclonal anti–laminin-5 (epiligrin, clone P3H9–2)
were obtained from Chemicon International. All secondary antibodies were
obtained from Jackson ImmunoResearch Laboratories.
E-cadherin–blocking peptide Ac-SHAVAS-NH2 and control peptide (Ac-
SVAHAS-NH2) were obtained from New England Peptide, Inc. PKC regula-
tor peptides pp94 and pp96 were obtained from the D. Mochly-Rosen
(Stanford University, Stanford, CA).
NHS biotinylation reagent and DSP were obtained from Pierce Chemical
Co.; recombinant mouse E-cadherin/Fc chimeric protein, Trichostatin A, and
MTT were obtained from Sigma-Aldrich; matrigel was obtained from BD
Biosciences; tyrosine phosphatase inhibitor bpV(phen) was obtained from
Calbiochem; human placental laminin (contains mainly laminin-10 and -11)
was obtained from Chemicon International; and laminin-1 was obtained
from BD Biosciences. N-Cadherin/Fc recombinant protein plasmid was ob-
tained from P. Doherty (Kings College, London, UK; Utton et al., 2001).
Oligonucleotides for PTP  RT-PCR were obtained from Invitrogen.
CD151 RNAi oligonucleotides were obtained from IDT. All other common
chemicals were obtained from Sigma-Aldrich and Bio-Rad Laboratories.
cDNA constructs
Construction of  6/ 3 chimeric integrins was performed as described
in Yauch et al. (2000).  6/ 3 chimeric integrins were subcloned in
pcDNA3.1 hygro ( ) vector.
Cell lines
Generation of wild-type and knockout immortalized cell lines from wild-
type and  3 mutant mouse kidney collecting ducts was performed as de-
scribed previously (B7 and B12 cells in Wang et al., 1999). To obtain the
 3- and  6-stalk cells, knockout cells were transfected with  6/ 3 chimeric
integrins in pCDNA3.1 hygro using calcium phosphate transfections and se-
lected for hygromycin resistance. Pools of transfected cells were FACS
®
sorted using anti–human  6 (A6-ELE) antibody. To culture cells on laminin-5,
SCC25 cells (which produce a laminin-5–rich matrix) were grown to conflu-
ence and removed (Xia et al., 1996) before plating cells under study.
Cell lysis and immunoprecipitation
Cells were grown in 10-cm dishes precoated with a laminin-5–rich ma-
trix. For immunoprecipitation and blotting of cadherin–catenin com-
plexes, cells were washed with PBS and lysed in lysis buffer (20 mM Tris,
pH 7.6, 1% Triton X-100, 2 mM CaCl2, 1 mM benzamidine, 0.1 mM am-
monium molybdate, 1 mM PMSF, 20  g/ml aprotinin, and 10  g/ml leu-
peptin). For  -catenin tyrosine phosphorylation assay, cells were pre-
treated with 1 mM sodium orthovanadate before lysis, and all the buffers
for immunoprecipitation and immunoblot were supplemented with 2
mM sodium orthovanadate.
In experiments where the interaction of  3 1–CD151 complex with
PKC II, RACK1, and PTP  was studied (Fig. 6) and in sequential immuno-
precipitations (Figs. 6 and 7), cells were incubated in 1 mM DSP for 1 h at
4 C (to cross-link the proteins) and treated as described by Berditchevski et
al. (1995). Integrin surface labeling and immunoprecipitations were con-
ducted as described previously (Wang et al., 1999).Integrin regulation of cell–cell adhesion | Chattopadhyay et al. 1361
Laminin adhesion assay
96-well plates were coated with human placental laminin (predominantly
laminin-10 and -11) or laminin-1 for 2 h at RT, and blocked with 1% BSA
in PBS containing 100 mM Ca
2  and 100 mM Mg
2  for 1 h. 2.5   10
4 cells
prepared by trypsinization in 200  l of medium containing 1% FCS were
added in each well for 1 h at RT, this being the maximal number of cells
that can adhere to a coated well. After washing out nonadherent cells, ad-
herent cells were incubated 3 h in medium containing 800  g/ml MTT so-
lution. The reaction product was measured at 595 nm. Each data point is
the mean of five wells, and SEMs are shown at the top of each bar in the
figures. The background level of binding, defined as the number of wild-
type cells adhering to a BSA-only well, usually 1–2% of the level of wild-
type cells binding to placental laminin, was subtracted from all results. In
pilot experiments, absorbance at 595 nm was directly proportional to the
number of adherent cells.
E-cadherin/Fc adhesion assay
Cells were treated as previously described (Higgins et al., 1998), 96-well
plates were coated with 1.5  g/ml recombinant mouse E-cadherin/Fc chi-
meric or with N-cadherin/Fc chimeric proteins and blocked with 1% BSA.
To test the effect of E-cadherin–blocking antibody or HAV peptide on cell
binding, cells were incubated in 5  g/ml antibody or 400  M HAV pep-
tide before adding to the wells. Adhesion was measured as described
above for the laminin binding assay.
Cell aggregation assay
Cells were trypsinized in the presence of calcium as described in the pre-
ceding section. A single cell suspension was obtained and 2.5   10
4 cells
were placed in a 0.2-ml tube and incubated on a rotation apparatus for 0,
1, or 3 h at RT. At the end of the incubation, cells were diluted into single
wells of a 6-well plate to prevent further aggregation. After allowing cells
to settle for 10 min at 33 C, the number of single cells and cells in clusters
were manually counted, counting 10 low-power fields using an inverted
tissue culture microscope. The percentage of cells in clusters was calcu-
lated as the number in clusters of five or more cells, divided by the total
number of single cells and cells in clusters. To study the effect of phos-
phatase inhibitor or PKC inhibitor peptides on cell–cell aggregation, cells
were treated with 1 mM bpV (phen) or 1  M PKC-regulating or control
peptide before trypsinization. In the case of HAV peptide (or control pep-
tide) or antibody treatment, cells were kept in suspension in the presence
of 5  g/ml anti–E-cadherin–blocking antibody or 400  M HAV peptide (or
control peptide).
Immunofluorescent staining
For immunofluorescent staining, the cells were grown overnight in 8-well
glass chamber slides coated with human placental laminin (source of lami-
nin-10 and -11). Cells were washed, fixed in 3% PFA, permeabilized with
5% NP-40, and blocked with 10% sheep serum. After blocking, the cells
were incubated with E-cadherin,  -catenin, or  -actinin antibodies, fol-
lowed by FITC-coupled IgG. For actin staining, cells were reacted with
Texas red–coupled phalloidin.
RT-PCR
Total RNA was isolated from cells as described previously (Chomczynski
and Sacchi, 1987). 7  g of total RNA was used for reverse transcription re-
action using Prostar first stand RT-PCR kit. First strand cDNA was synthe-
sized as described by the manufacturer (Stratagene). The resulting cDNA
was subjected to PCR amplification reaction using primers 5 -ACCTCCTC-
CAACACATCAC-3  and 5 -TCACGGACACTGTAGAACTC-3  and follow-
ing protocol supplied by QIAGEN. The PCR product was visualized using
ethidium bromide in 1% agarose gel.
Baculovirus production
Using the pBacMam-2 vector obtained from Novagen, the following con-
structs were generated: wild-type PTP  and a catalytically inactive (C-S)
mutant form of PTP . This vector system allows expression of exogenous
genes in mammalian cells using recombinant baculoviruses. The wild-type
PTP  tagged with the GFP at the COOH terminus and the catalytically in-
active (C-S) mutant PTP -GFP have been described previously (Burden-
Gulley and Brady-Kalnay, 1999). The pBPSTR1 plasmids were digested
with NotI and the PTP -GFP–encoding DNA was ligated into the pBac-
MAM-2 vector (Novagen) that had been digested with NotI. The recombi-
nant baculoviruses were made using the BaculoGold Transfection System
(Invitrogen). In brief, recombinant baculoviruses were generated by cal-
cium phosphate-mediated cotransfection of Sf9 cells with plasmid and vi-
ral DNA. Four rounds of virus amplification were performed. The virus was
harvested from the Sf9 cells 4 d after infection. To infect mammalian cells,
500  l of viral supernatant was added to a 10-cm dish of cells containing 4
ml of media and incubated at 37 C for 2 h. After incubation all the culture
media was removed and fresh media containing a final concentration of
150 nM Trichostatin A (Sigma-Aldrich) was added to the cultures. 16 to 24 h
after virus addition, PTP  expression was analyzed by FACS
®. Exogenous
PTP  expression was also verified by immunoblotting lysates from infected
cells with antibodies to PTP .
CD151 RNAi
Three sequences were selected from mouse CD151 gene, which were pre-
dicted to form CD151 shRNA. The oligos were inserted into pLentilo 3.7
vector obtained from L. van Parijs (Massachusetts Institute of Technology;
Rubinson et al., 2003) to generate pLL CD151–1, pLL-CD151–2, and pLL-
CD151–3, and cotransfected with packaging vectors into 293T cells. This
vector expresses shRNA and GFP, each from distinct promoters. The len-
tivirus in the supernatant was collected after 24 h and used directly to in-
fect the wild-type cell line; GFP expression was maximum after 48 h of
infection. Immunoprecipitation, immunofluorescence, and cell–cell aggre-
gation assay were done after 48 h of infection.
Online supplemental material
Fig. S1 shows in vitro phosphatase assays demonstrating the activity of en-
dogenous and baculoviral PTP . Fig. S2 demonstrates similar behavior of
cells plated on fibronectin or laminin. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200306067/DC1.
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